Draft:Hammer Toe Orthopedic Surgery

Nextremity Solutions, Inc. Receives FDA 510(k) Clearance for Cannulated Hammertoe System

Retrieved on: 
Friday, July 3, 2020

The DuoHex CH System addresses hammertoe deformity in patients and provides surgeons with a novel two-piece threaded implant construct is designed for optimum bone purchase.

Key Points: 
  • The DuoHex CH System addresses hammertoe deformity in patients and provides surgeons with a novel two-piece threaded implant construct is designed for optimum bone purchase.
  • The design of the cannulated implants and instruments provide targeting and technique guidance for repeatable outcomes.
  • Ryan Schlotterback, Chief Technology Officer for Nextremity Solutions said, "Nextremity Solutions was founded years ago by surgeons with a passion for the foot and ankle market and with an innovative solution for hammertoe correction.
  • The Nextremity Solutions DuoHex CH Cannulated Hammertoe System is indicated for small bone reconstruction limited to interphalangeal repair and fusion of the lesser toes.